[go: up one dir, main page]

PE20090444A1 - Eteres heterociclicos sustituidos y su uso en trastornos del snc - Google Patents

Eteres heterociclicos sustituidos y su uso en trastornos del snc

Info

Publication number
PE20090444A1
PE20090444A1 PE2008001169A PE2008001169A PE20090444A1 PE 20090444 A1 PE20090444 A1 PE 20090444A1 PE 2008001169 A PE2008001169 A PE 2008001169A PE 2008001169 A PE2008001169 A PE 2008001169A PE 20090444 A1 PE20090444 A1 PE 20090444A1
Authority
PE
Peru
Prior art keywords
alkyl
cns disorders
cyane
haloalkyl
halo
Prior art date
Application number
PE2008001169A
Other languages
English (en)
Inventor
Andrew P Degnan
George O Tora
Vivekananda M Vrudhula
John E Macor
Joanne J Bronson
Derek J Denhart
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20090444A1 publication Critical patent/PE20090444A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 ES H, ALQUILO; R2 ES H, ALQUILO, CIANOALQUILO, HALOALQUILO, HIDROXIALQUILO, CIANO, ENTRE OTROS; R3 ES H, ALQUILO; Ar1 ES FENILO, PIRIDILO CON 0-3 SUSTITUYENTES SELECCIONADOS DE HALO, ALQUILO, HALOALQUILO, CIANO; Ar2 ES INDOLILO, INDAZOLILO, BENZIMIDAZILO CON 0-3 SUSTITUYENTES SELECCIONADOS DE HALO, ALQUILO, CICLALQUILO, ENTRE OTROS; Ar3 ES FENILO CON 0-3 SUSTITUYENTES SELECCIONADOS DE HALO, ALCOXI, CIANO, HALOALQUILO. SON COMPUESTOS PREFERIDOS: 7-METIL-5-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-1H-INDAZOL; 2,5-DIMETIL-7-(((4-FENILPIPERIDIN-4-IL)METOXI)METIL)-2H-INDAZOL; ENTRE OTROS. DICHOS COMPUESTOS SON INHIBIDORES DE LA RECAPTACION DE SEROTONINA CON ANTAGONISMO DE NK-1 UTIL EN EL TRATAMIENTO DE TRASTORNOS DEL SNC
PE2008001169A 2007-07-11 2008-07-11 Eteres heterociclicos sustituidos y su uso en trastornos del snc PE20090444A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94901307P 2007-07-11 2007-07-11
US12/165,967 US8026257B2 (en) 2007-07-11 2008-07-01 Substituted heterocyclic ethers and their use in CNS disorders

Publications (1)

Publication Number Publication Date
PE20090444A1 true PE20090444A1 (es) 2009-04-18

Family

ID=39764827

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001169A PE20090444A1 (es) 2007-07-11 2008-07-11 Eteres heterociclicos sustituidos y su uso en trastornos del snc

Country Status (6)

Country Link
US (1) US8026257B2 (es)
AR (1) AR067528A1 (es)
CL (1) CL2008002041A1 (es)
PE (1) PE20090444A1 (es)
TW (1) TW200906407A (es)
WO (1) WO2009009411A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7861969B2 (en) 2007-05-24 2011-01-04 The Boeing Company Shaped composite stringers and methods of making
US7879276B2 (en) 2007-11-08 2011-02-01 The Boeing Company Foam stiffened hollow composite stringer
US7632861B2 (en) * 2007-11-13 2009-12-15 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
MX2011005090A (es) 2008-11-14 2011-09-06 Theravance Inc Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)feni l] piperidina.
US8500066B2 (en) 2009-06-12 2013-08-06 The Boeing Company Method and apparatus for wireless aircraft communications and power system using fuselage stringers
US8617687B2 (en) 2009-08-03 2013-12-31 The Boeing Company Multi-functional aircraft structures
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
WO2011085291A1 (en) 2010-01-11 2011-07-14 Theravance, Inc. 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
JP5769348B2 (ja) * 2010-03-22 2015-08-26 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー １−（２−フェノキシメチルヘテロアリール）ピペリジン化合物および１−（２−フェノキシメチルヘテロアリール）ピペラジン化合物
MX374759B (es) 2013-12-13 2025-03-06 Hoffmann La Roche Inhibidores de tirosina cinasa de bruton.
CA2931189C (en) 2013-12-13 2017-09-26 F. Hoffmann-La Roche Ag Inhibitors of bruton's tyrosine kinase
UA120651C2 (uk) 2015-06-09 2020-01-10 Еббві Інк. Модулятори ядерних рецепторів
WO2016198908A1 (en) 2015-06-09 2016-12-15 Abbvie Inc. Ror nuclear receptor modulators
KR101966736B1 (ko) * 2015-09-15 2019-04-09 주식회사 엘지화학 변성 폴리이미드 및 이를 포함하는 경화성 수지 조성물
KR20190084310A (ko) 2016-11-23 2019-07-16 바이엘 크롭사이언스 악티엔게젤샤프트 살충제로서의 2-[3-(알킬술포닐)-2H-인다졸-2-일]-3H-이미다조[4,5-b]피리딘 유도체 및 유사한 화합물
CN116003325B (zh) * 2023-01-09 2025-04-25 南方医科大学 吲唑类化合物或其药学上可接受的盐及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337418C (en) 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
DE69327541T2 (de) 1992-10-28 2000-08-10 Merck Sharp & Dohme Ltd., Hoddesdon 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
ATE170174T1 (de) 1994-01-13 1998-09-15 Merck Sharp & Dohme Gem-bissubstituierte azazyclische tachykinin- antagonisten
IL163939A0 (en) 2002-03-13 2005-12-18 Schering Corp Nk1 antagonists
JP4592077B2 (ja) 2002-07-03 2010-12-01 シェーリング コーポレイション 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−１（ｎｋ−１）アンタゴニストとしての１−アミド−４−フェニル−４−ベンジルオキシメチル−ピペリジン誘導体および関連化合物
JP2006502157A (ja) 2002-09-09 2006-01-19 アストラゼネカ・アクチエボラーグ ナフチルエーテル化合物及びそれらの使用
US7494986B2 (en) 2004-07-20 2009-02-24 Bristol-Myers Squibb Company Cycloalkylamine derivatives as NK-1/SSRI antagonists
FR2883876B1 (fr) 2005-03-30 2007-05-04 Servier Lab Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20070249607A1 (en) 2006-04-17 2007-10-25 Bristol-Myers Squibb Company Nk-1 and serotonin transporter inhibitors
EP2069328A2 (en) 2006-07-27 2009-06-17 Brystol-Myers Squibb Company 4-arylalkoxymethyl-4-phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders

Also Published As

Publication number Publication date
US8026257B2 (en) 2011-09-27
WO2009009411A1 (en) 2009-01-15
AR067528A1 (es) 2009-10-14
CL2008002041A1 (es) 2009-01-09
TW200906407A (en) 2009-02-16
US20090018132A1 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
PE20090444A1 (es) Eteres heterociclicos sustituidos y su uso en trastornos del snc
PE20040512A1 (es) Compuesto de pirazol-pirimidina anilina
MXPA05010652A (es) Pirazoles sustituidos.
CO6140060A2 (es) Derivados de aminocicloalquil 1,2,4-triazol como moduladores de mglur5
PE20011334A1 (es) Compuestos y composiciones de indazol de formula (i)
NO20051694L (no) Heterosykliske forbindelser
PE20120798A1 (es) Potentes inhibidores de molecula pequena de autofagia
PE20130774A1 (es) Compuestos heterociclicos activadores de ampk y metodos para emplearlos
ATE443701T1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
BG104842A (en) New hydroxyindoles, their use as phosphodiesterase 4 inhibitiors and methods for producing same
PE20130325A1 (es) Derivados de piperidina, piperazina o tetrahidropiridilo como antagonistas de trpv1
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
PE20110570A1 (es) Heterociclos biciclicos sustituidos
AR062965A1 (es) Compuestos moduladores de receptores de glutamatometabotropicos mglur5, composiciones farmaceuticas que los contienen y usos terapeuticos en trastornos gastrointestinales, neurologicos y psiquiatricos agudos y cronicos
AR028817A1 (es) Compuestos derivados de la 1-arenosulfonil-2-arilo-pirrolidina, su empleo, un procedimiento para obtenerlos y medicamentos que los contienen
AR060813A1 (es) Moduladores de mglur5 iii
ATE478054T1 (de) Benzimidazolderivate
MXPA05010646A (es) Pirazoles sustituidos.
PE20091524A1 (es) Derivados de 2-aminopirimidina
EA201070321A1 (ru) Замещённые пиперазинил-пиразины и пиридины в качестве антагонистов рецепторов 5-нт
ATE503755T1 (de) Cgrp-rezeptorantagonisten
PE20071225A1 (es) Compuestos derivados de piperidina como inhibidores de neurocinina-1 (nk-1) y del transportador de serotonina
RS51979B (en) PYRIMIDINYL-PIPERAZINE USED AS D3 / D2 LIGAND RECEPTOR
MXPA05010651A (es) Compuestos de pirazol.
PE20060770A1 (es) Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1

Legal Events

Date Code Title Description
FD Application declared void or lapsed